Stockreport

Intra-Cellular drug approval augurs well for CNS stocks, Stifel says [Seeking Alpha]

Intra-Cellular Therapies Inc.  (ITCI) 
Last intra-cellular therapies inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intracellulartherapies.com/investor-relations
PDF The FDA's approval of Intra-Cellular Therapies' ( ITCI +191.6% He points to Sage Therapeutics ( SAGE -1.1% ACAD -1.7% KRTX -7.3% BIIB +0.6% The recent approval shows tha [Read more]